Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label (OL) Extension Study to Assess Safety of PROCRIT (Epoetin Alfa) in Patients With Anemia of Chronic Disease (ACD) Due to Rheumatoid Arthritis (RA)

NCT00123149 is registered in ClinicalTrials.gov with Ortho Biotech Products, L.P. as lead sponsor.

NCT NCT00123149
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00123149 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label (OL) Extension Study to Assess Safety of PROCRIT (Epoetin Alfa) in Patients With Anemia of Chronic Disease (ACD) Due to Rheumatoid Arthritis (RA)
Lead sponsor
Ortho Biotech Products, L.P.
Phase
Phase 2
Overall status
Withdrawn
Start date
Not reported
Completion date
October 31, 2007
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, rheumatoid arthritis